Nasdaq

Masimo Announces FDA Clearance of the Rad-G® with Temperature

Joe Kiani, Founder and CEO of Masimo, said, “With Rad-G, we set out to create an accessible, high-quality care solution that could be used in a multitude of care settings to serve the five billion ...
Business Wire

Masimo Announces CE Marking of the Rad-G™ with Temperature

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET ® pulse ...
Business Wire

Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the ...
Nasdaq

Masimo's (MASI) Rad-G Clinical Study Trial Outcome Favorable

Masimo Corporation MASI recently announced the findings of a study published in Clinical Medicine Insights: Pediatrics, demonstrating the experience using the Masimo Rad-G Pulse Oximeter. The study ...
Business Wire

Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology

In 2016, Saudi Arabia implemented a mandatory CCHD screening program for all newborns using the Masimo Eve™ Newborn Screening Application on Radical-7 ® Pulse CO-Oximeters ® with SET ® Measure-through ...